- Home
- AIR vs TERN Comparison
AIR vs TERN Comparison
Compare AIR & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIR | TERN |
|---|---|---|
| Founded | 1951 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.5B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIR | TERN |
|---|---|---|
| Price | $107.80 | $43.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $113.80 | $48.60 |
| AVG Volume (30 Days) | 311.4K | ★ 1.5M |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.81 |
| EPS | ★ 1.85 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.67 | N/A |
| Revenue Next Year | $10.51 | N/A |
| P/E Ratio | $60.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $46.51 | $1.87 |
| 52 Week High | $121.64 | $48.26 |
Technical Indicators
Market Signals| Indicator | AIR | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 67.72 |
| Support Level | $73.30 | $39.15 |
| Resistance Level | $118.00 | $48.26 |
| Average True Range (ATR) | 3.73 | 2.29 |
| MACD | -1.44 | 0.20 |
| Stochastic Oscillator | 6.58 | 85.85 |
Price Performance
Historical ComparisonAbout AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.